$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Less is more: level IB-sparing radiation therapy in nasopharyngeal cancer 원문보기

Radiation oncology journal : ROJ, v.41 no.1, 2023년, pp.1 - 3  

Oh, Dongryul (Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea)

초록이 없습니다.

참고문헌 (24)

  1. 1 Bray F Ferlay J Soerjomataram I Siegel RL Torre LA Jemal A Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 2018 68 394 424 30207593 

  2. 2 Ministry of Health and Welfare Annual report of cancer statistics in Korea in 2019 Goyang, Korea National Cancer Center 2021 

  3. 3 Wei WI Sham JS Nasopharyngeal carcinoma Lancet 2005 365 2041 54 15950718 

  4. 4 Tang L Mao Y Liu L The volume to be irradiated during selective neck irradiation in nasopharyngeal carcinoma: analysis of the spread patterns in lymph nodes by magnetic resonance imaging Cancer 2009 115 680 8 19117352 

  5. 5 Ho FC Tham IW Earnest A Lee KM Lu JJ Patterns of regional lymph node metastasis of nasopharyngeal carcinoma: a meta-analysis of clinical evidence BMC Cancer 2012 12 98 22433671 

  6. 6 Lee N Harris J Garden AS Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225 J Clin Oncol 2009 27 3684 90 19564532 

  7. 7 Kam MK Teo PM Chau RM Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience Int J Radiat Oncol Biol Phys 2004 60 1440 50 15590175 

  8. 8 Shen G Zhang W Jia Z Li J Wang Q Deng H Meta-analysis of diagnostic value of 18F-FDG PET or PET/CT for detecting lymph node and distant metastases in patients with nasopharyngeal carcinoma Br J Radiol 2014 87 20140296 25348201 

  9. 9 Lee AW Ng WT Pan JJ International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma Radiother Oncol 2018 126 25 36 29153464 

  10. 10 Sun Z Wang J Huang R Contralateral lower neck sparing radiotherapy in stage N1 nasopharyngeal carcinoma: long-term survival outcomes and late toxicities Front Oncol 2021 11 628919 33718204 

  11. 11 Wang G Huang C Yang K Neck level Ib-sparing versus level Ib-irradiation in intensity-modulated radiotherapy for the treatment of nasopharyngeal carcinoma with high-risk factors: a propensity score-matched cohort study Radiother Oncol 2022 177 205 13 36375564 

  12. 12 Tang LL Tang XR Li WF The feasibility of contralateral lower neck sparing intensity modulation radiated therapy for nasopharyngeal carcinoma patients with unilateral cervical lymph node involvement Oral Oncol 2017 69 68 73 28559023 

  13. 13 Zeng L Sun XM Chen CY Comparative study on prophylactic irradiation to the whole neck and to the upper neck for patients with neck lymph node-negative nasopharyngeal carcinoma Head Neck 2014 36 687 93 23606573 

  14. 14 Guo Q Xiao N Xu H Level Ib sparing intensity-modulated radiation therapy in selected nasopharyngeal carcinoma patients based on the International Guideline Radiother Oncol 2022 167 239 43 34973279 

  15. 15 Zhang F Cheng YK Li WF Investigation of the feasibility of elective irradiation to neck level Ib using intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma: a retrospective analysis BMC Cancer 2015 15 709 26472233 

  16. 16 Chen J Ou D He X Hu C Sparing level Ib lymph nodes by intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma Int J Clin Oncol 2014 19 998 1004 24337503 

  17. 17 Ou X Miao Y Wang X Ding J He X Hu C The feasibility analysis of omission of elective irradiation to level IB lymph nodes in low-risk nasopharyngeal carcinoma based on the 2013 updated consensus guideline for neck nodal levels Radiat Oncol 2017 12 137 28821277 

  18. 18 Tang LL Huang CL Zhang N Elective upper-neck versus whole-neck irradiation of the uninvolved neck in patients with nasopharyngeal carcinoma: an open-label, non-inferiority, multicentre, randomised phase 3 trial Lancet Oncol 2022 23 479 90 35240053 

  19. 19 Kim D Keam B Ahn SH Choi CH Wu HG Feasibility and safety of neck level IB-sparing radiotherapy in nasopharyngeal cancer: a long-term single institution analysis Radiat Oncol J 2022 40 260 9 36606303 

  20. 20 Ahn YC Kim YS Korean perspectives of nasopharynx cancer management Chin Clin Oncol 2016 5 28 27121888 

  21. 21 Hawkins PG Lee JY Mao Y Sparing all salivary glands with IMRT for head and neck cancer: longitudinal study of patient-reported xerostomia and head-and-neck quality of life Radiother Oncol 2018 126 68 74 28823405 

  22. 22 Nevens D Duprez F Daisne JF Reduction of the dose of radiotherapy to the elective neck in head and neck squamous cell carcinoma; a randomized clinical trial: effect on late toxicity and tumor control Radiother Oncol 2017 122 171 7 27528118 

  23. 23 Maguire PD Neal CR Hardy SM Schreiber AM Single-arm phase 2 trial of elective nodal dose reduction for patients with locoregionally advanced squamous cell carcinoma of the head and neck Int J Radiat Oncol Biol Phys 2018 100 1210 6 29452770 

  24. 24 Cho WK Oh D Lee E Feasibility of selective neck irradiation with lower elective radiation dose in treating nasopharynx cancer patients Cancer Res Treat 2019 51 603 10 30025444 

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로